D.E. Shaw & Co’s Sana Biotechnology SANA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $56.8K | Sell |
20,792
-31,170
| -60% | -$85.1K | ﹤0.01% | 2928 |
|
2025
Q1 | $87.3K | Buy |
+51,962
| New | +$87.3K | ﹤0.01% | 2855 |
|
2024
Q4 | – | Sell |
-47,347
| Closed | -$197K | – | 3335 |
|
2024
Q3 | $197K | Buy |
+47,347
| New | +$197K | ﹤0.01% | 2823 |
|
2024
Q1 | – | Sell |
-254,403
| Closed | -$1.04M | – | 3367 |
|
2023
Q4 | $1.04M | Buy |
254,403
+1,634
| +0.6% | +$6.67K | ﹤0.01% | 2051 |
|
2023
Q3 | $978K | Sell |
252,769
-35,385
| -12% | -$137K | ﹤0.01% | 2045 |
|
2023
Q2 | $1.72M | Sell |
288,154
-239,030
| -45% | -$1.42M | ﹤0.01% | 1819 |
|
2023
Q1 | $1.72M | Sell |
527,184
-99,013
| -16% | -$324K | ﹤0.01% | 1928 |
|
2022
Q4 | $2.47M | Buy |
626,197
+89,480
| +17% | +$353K | ﹤0.01% | 1912 |
|
2022
Q3 | $3.22M | Buy |
536,717
+51,922
| +11% | +$312K | ﹤0.01% | 1807 |
|
2022
Q2 | $3.12M | Buy |
484,795
+244,246
| +102% | +$1.57M | ﹤0.01% | 1964 |
|
2022
Q1 | $1.99M | Sell |
240,549
-47,552
| -17% | -$393K | ﹤0.01% | 2435 |
|
2021
Q4 | $4.46M | Buy |
288,101
+40,512
| +16% | +$627K | ﹤0.01% | 1773 |
|
2021
Q3 | $5.58M | Buy |
+247,589
| New | +$5.58M | 0.01% | 1392 |
|